Endo’s end around: How a huge Philadelphia-based opioid maker escaped a $7 billion federal penalty
This article was produced in partnership with ProPublica. Sign up for Dispatches to get ProPublica stories like this one as soon as they are published. This spring, the Justice Department announced a major victory against a drug firm that manufactured …